Pulmonary embolism as a first clinical sign of occult malignancy: A prospective follow-up study

• References

• 1 Baron JA, Gridley G, Weiderpass E. et al. Venous thromboembolism and cancer. Lancet 1998; 351: 1077-80.
• 2 Bastounis EA, Karayiannakis AJ, Makri GG. et al. The incidence of occult cancer in patients with deep venous thrombosis: a prospective study. J Intern Med 1996; 239: 153-6.
• 3 Monreal M, Lafoz E, Casals A. et al. Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer 1991; 67: 541-5.
• 4 Monreal M, Casals A, Boix J. et al. Occult cancer in patients with acute pulmonary embolism. A prospective study. Chest 1993; 103: 816-9.
• 5 Prandoni P, Lensing AW, Buller HR. et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-33.
• 6 Sorensen HT, Mellemkjaer L, Steffensen FH. et al. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.
• 7 Taliani MR, Agnelli G, Prandoni P. et al. Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. J Thromb Haemost 2003; 01: 1730-3.
• 8 Heit JA, Silverstein MD, Mohr DN. et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-63.
• 9 Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPIGETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-60.
• 10 van Strijen MJ, Bloem JL, de Monye W. et al. Helical computed tomography and alternative diagnosis in patients with excluded pulmonary embolism. J Thromb Haemost 2005; 03: 2449-56.
• 11 Prins MH, Lensing AW, Hirsh J. Idiopathic deep venous thrombosis. Is a search for malignant disease justified? Arch Intern Med 1994; 154: 1310-2.
• 12 Monreal M. Screening for occult cancer in patients with acute venous thromboembolism. J Thromb Haemost 2005; 03: 2389-90.